There are several, identifiable risk factors for postburn pathologic scarring, and early identification of patients most at risk can help ensure they get optimum treatment, according to a report published in the March/April issue of the Archives of Facial Plastic Surgery.
TUESDAY, March 18 (HealthDay News) -- There are several, identifiable risk factors for postburn pathologic scarring, and early identification of patients most at risk can help ensure they get optimum treatment, according to a report published in the March/April issue of the Archives of Facial Plastic Surgery.
Ezio Nicola Gangemi, M.D., and colleagues at the University of Turin in Turin, Italy, analyzed data on 703 patients with 2,440 anatomic burn sites treated between 1994 and 2006. They assessed the risk of postburn pathologic scarring by age, sex, nature and severity of the burn, and a range of factors associated with treatment such as type of surgery and skin graft.
In all, 540 patients (77 percent) were diagnosed with pathologic scarring, 310 (44 percent) had hypertrophic scars, 196 (28 percent) had hypertrophic-contracted scars and 34 (5 percent) had contractures. There were a number of independent risk factors for pathologic scarring, including female sex, young age, burn sites on the neck and upper limbs, multiple surgical procedures and meshed skin grafts.
"Following the maxim that prevention of complications is preferable to treatment of an established problem, burn care specialists are searching for clinical criteria to identify patients who might benefit from prophylactic programs," the authors write. "To our knowledge, the present study is the first to investigate risk prediction models for pathologic postburn scarring."
AbstractFull Text (subscription or payment may be required)
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.